Prevalence and Distribution of E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016

Contemporary data on the prevalence of e-cigarette use in the United States are limited. To report the prevalence and distribution of current e-cigarette use among U.S. adults in 2016. Cross-sectional. Behavioral Risk Factor Surveillance System, 2016. Adults aged 18 years and older. Prevalence of cu...

Full description

Saved in:
Bibliographic Details
Published in:Annals of internal medicine Vol. 169; no. 7; pp. 429 - 438
Main Authors: Mirbolouk, Mohammadhassan, Charkhchi, Paniz, Kianoush, Sina, Uddin, S M Iftekhar, Orimoloye, Olusola A, Jaber, Rana, Bhatnagar, Aruni, Benjamin, Emelia J, Hall, Michael E, DeFilippis, Andrew P, Maziak, Wasim, Nasir, Khurram, Blaha, Michael J
Format: Journal Article
Language:English
Published: United States American College of Physicians 02-10-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Contemporary data on the prevalence of e-cigarette use in the United States are limited. To report the prevalence and distribution of current e-cigarette use among U.S. adults in 2016. Cross-sectional. Behavioral Risk Factor Surveillance System, 2016. Adults aged 18 years and older. Prevalence of current e-cigarette use by sociodemographic groups, comorbid medical conditions, and states of residence. Of participants with information on e-cigarette use (n = 466 842), 15 240 were current e-cigarette users, representing a prevalence of 4.5%, which corresponds to 10.8 million adult e-cigarette users in the United States. Of the e-cigarette users, 15% were never-cigarette smokers. The prevalence of current e-cigarette use was highest among persons aged 18 to 24 years (9.2% [95% CI, 8.6% to 9.8%]), translating to approximately 2.8 million users in this age range. More than half the current e-cigarette users (51.2%) were younger than 35 years. In addition, the age-standardized prevalence of e-cigarette use was high among men; lesbian, gay, bisexual, and transgender (LGBT) persons; current combustible cigarette smokers; and those with chronic health conditions. The prevalence of e-cigarette use varied widely among states, with estimates ranging from 3.1% (CI, 2.3% to 4.1%) in South Dakota to 7.0% (CI, 6.0% to 8.2%) in Oklahoma. Data were self-reported, and no biochemical confirmation of tobacco use was available. E-cigarette use is common, especially in younger adults, LGBT persons, current cigarette smokers, and persons with comorbid conditions. The prevalence of use differs across states. These contemporary estimates may inform researchers, health care policymakers, and tobacco regulators about demographic and geographic distributions of e-cigarette use. American Heart Association Tobacco Regulation and Addiction Center, which is funded by the U.S. Food and Drug Administration and National Heart, Lung, and Blood Institute.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author Contributions: Conception and design: M. Mirbolouk, P. Charkhchi, S. Kianoush, O.A. Orimoloye, A. Bhatnagar, A.P. DeFilippis, W. Maziak, M.J. Blaha.
Dr. Blaha: 600 North Wolfe Street, Blalock 524D1, Baltimore, MD 21287.
Analysis and interpretation of the data: M. Mirbolouk, P. Charkhchi, S. Kianoush, S.M.I. Uddin, O.A. Orimoloye, A. Bhatnagar, A.P. DeFilippis, M.J. Blaha.
Current author addresses and author contributions are available at Annals.org.
Drs. Jaber, Maziak, and Nasir: 11200 Southwest 8th Street, AHC5, Miami, FL 33199.
Dr. Hall: 2500 North State Street, Jackson, MS 39216.
Collection and assembly of data: M. Mirbolouk, P. Charkhchi, M.J. Blaha.
Final approval of the article: M. Mirbolouk, P. Charkhchi, S. Kianoush, S.M.I. Uddin, O.A. Orimoloye, R. Jaber, A. Bhatnagar, E.J. Benjamin, M.E. Hall, A.P. DeFilippis, W. Maziak, K. Nasir, M.J. Blaha.
Administrative, technical, or logistic support: M. Mirbolouk, P. Charkhchi, M.J. Blaha.
Critical revision for important intellectual content: M. Mirbolouk, P. Charkhchi, S. Kianoush, S.M.I. Uddin, O.A. Orimoloye, R. Jaber, A. Bhatnagar, E.J. Benjamin, M.E. Hall, A.P. DeFilippis, W. Maziak, K. Nasir, M.J. Blaha.
Statistical expertise: M. Mirbolouk, P. Charkhchi, S.M.I. Uddin, M.J. Blaha.
Obtaining of funding: A. Bhatnagar, M.J. Blaha.
Drafting of the article: M. Mirbolouk, P. Charkhchi, S. Kianoush, S.M.I. Uddin, O.A. Orimoloye, A.P. DeFilippis, W. Maziak, K. Nasir, M.J. Blaha.
Current Author Addresses: Drs. Mirbolouk, Charkhchi, Kianoush, Uddin, and Orimoloye: 600 North Wolfe Street, Blalock 501, Baltimore, MD 21287.
Dr. Benjamin: 88 East Newton Street, 8th Floor, Suite C, Boston, MA 02118.
Drs. Bhatnagar and DeFilippis: 550 South Jackson Street, 3rd Floor, Louisville, Kentucky 40202.
Provision of study materials or patients: M. Mirbolouk, P. Charkhchi, M.J. Blaha.
ISSN:0003-4819
1539-3704
DOI:10.7326/M17-3440